Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid LeukemiaSHAH, Neil P ; KANTARJIAN, Hagop M ; KHOROSHKO, Nina ; PAQUETTE, Ronald L ; DEININGER, Michael ; COLLINS, Robert H ; OTERO, Irma ; HUGHES, Timothy ; BLEICKARDT, Eric ; STRAUSS, Lewis ; FRANCIS, Stephen ; HOCHHAUS, Andreas ; KIM, Dong-Wook ; REA, Delphine ; DORLHIAC-LLACER, Pedro E ; MILONE, Jorge H ; VELA-OJEDA, Jorge ; SILVER, Richard T ; KHOURY, H. Jean ; CHARBONNIER, AudeJournal of clinical oncology, 2008-07, Vol.26 (19), p.3204-3212 [Periódico revisado por pares]Baltimore, MD: American Society of Clinical OncologyTexto completo disponível |